DIOSynVax: Funding, Investors & Team (Oct 2026)
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
DIOSynVax has raised $42.0M across 1 funding round on record, the most recent a Grant of $42.0M announced in Mar 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
DIOSynVax Company Profile and Key Stats
Latest funding round on record: Mar 2022.
DIOSynVax Funding Rounds
DIOSynVax Founders and Leadership Team
Contact details for the DIOSynVax team: 1 of 1 has an email address on file.
Start 14-day free trial →DIOSynVax Funding Compared to Other Biotechnology Startups
DIOSynVax's latest round of $42.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like DIOSynVax in Biotechnology and Cambridge
Companies Similar to DIOSynVax
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
DIOSynVax Funding FAQs
What does DIOSynVax do?
DIOSyn Vax (Digitally designed, Immune Optimised Selected and Synthesized Vaccines) is new technology that will significantly accelerate vaccine development and achieve dramatic improvements to the protection against emerging and re-emerging pathogens.
How much funding has DIOSynVax raised?
DIOSynVax has raised $42.0M across 1 round on record. The most recent is a Grant of $42.0M announced in Mar 2022.
When did DIOSynVax last raise funding?
DIOSynVax's most recent funding round on record is a Grant of $42.0M, announced in Mar 2022.
Who is the CEO of DIOSynVax?
Jonathan Heeney is listed as CEO at DIOSynVax.
Where is DIOSynVax headquartered?
DIOSynVax is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does DIOSynVax have?
DIOSynVax is in the 11-50 employee band.
How does DIOSynVax's funding compare to other Biotechnology startups?
DIOSynVax's latest round of $42.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's DIOSynVax Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for DIOSynVax is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.